Phage Nanobiotechnology
Symposium Chairs |
|||
|
|||
Confirmed Invited Speakers |
|||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
Special Symposium
A new promising type of nanomaterials—bacteriophages—emerged recently as a result of evolution of phage display technique. In opposite to other nanomaterials, the bacteriophages have the unique feature—their structure and function are encrypted in their genomic DNA, which can be intentionally modified or even rewritten using routine genetic engineering techniques. Phage as a new kind of nanomaterials attracts attention of specialists working in boundary, and even very distal areas from genetics and molecular biology, such as pharmaceutical science, material science, microelectronics, biosensors, detection, environmental sciences, etc. Penetration of the phage technology into these new disciplines requires development of new concepts, which will be the focus of the symposium. The symposium will introduce new researchers into this hot new area of phage nanobiotechnology, summarize the existing data on the phage nanomaterials and discuss a prospect of their use in different areas of medicine, science and technology.
Symposium Sessions | ||
Monday May 4 | ||
| 10:30 | Phage Nanotechnology | |
| 1:30 | Phage Nanotechnology | |
| 4:00 | Phage Nanotechnology | |
Tuesday May 5 | ||
| 8:00 | Keynotes: Nanotech & Cleantech & TechConnect | |
| 4:00 | POSTERS | |
| Phage Nanotechnology | ||
Wednesday May 6 | ||
| 1:30 | POSTERS | |
Thursday May 7 | ||
Symposium Program | ||
Monday May 4 | ||
| Back to Top | ||
| 10:30 | Phage Nanotechnology | Room 351 BE |
| Session chair: Valery A. Petrenko, Auburn University, US | ||
| 10:30 | Phage Paradigm in Development of Targeted Medications V.A. Petrenko, Auburn University, US (bio) | |
| 10:55 | (CANCELED) Massively Parallel Affinity Selection with Complex Selectors G.P. Smith, W.D. Thomas, University of Missouri, US | |
| 11:20 | Therapeutic Implications of Combinatorial Vascular Targeting R. Pasqualini, W. Arap, The University of Texas M. D. Anderson Cancer Center, US | |
| 11:45 | Engineering the filamentous phage surface to alter its immunogenicity N.E. van Houten, K. Henry, G.P. Smith, J.K. Scott, Simon Fraser University, CA | |
| Back to Top | ||
| 1:30 | Phage Nanotechnology | Room 351 BE |
| Session chair: Valery A. Petrenko, Auburn University, US | ||
| 1:30 | To ‘L’ and back – the odyssee of membrane bound M13 major coat protein W.L. Vos, NUI Maynooth, IE | |
| 2:00 | Engineered phage banks: targetable nanodevices as a functional answer to bacteriological threats F. Iris, BioModeling Systems, FR | |
| 2:30 | Self replicating nanoparticles which auto-assemble and package specific DNA sequences (bacteriophages) as vaccine delivery vehicles J. Clark, J. March, BigDNA Ltd., UK | |
| 3:00 | Gold Nanoparticle-based Scaffolds for Targeted Imaging and Tissue Ablation R. Pasqualini, W. Arap, The University of Texas M. D. Anderson Cancer Center, US | |
| Back to Top | ||
| 4:00 | Phage Nanotechnology | Room 351 BE |
| Session chair: Valery A. Petrenko, Auburn University, US | ||
| 4:00 | Phage reporter biosensing of pathogenic agents S. Ripp, University of Tennessee, US | |
| 4:30 | Assembly of hydroxylapatite nanoparticles on hydroxylapatite-binding phage selected from a landscape phage library B. Cao, S. Modali, G. Abbineni, P. Jayanna, V.A. Petrenko, C. Mao, University of Oklahoma, US | |
| 5:00 | Molecular Imaging and Biomarker Discovery in Pancreatic Ductal Adenocarcinoma K. Kelly, University of Virginia, US | |
| 5:20 | Bio-Directed Synthesis and Assembly of Nanomaterials J.M. Slocik, M. Dickerson, S-N. Kim, M. Tomczak, L.F. Drummy, R.R. Naik, Air Force Research Laboratory, US | |
| 5:40 | Site-Directed Chemical Modification of Phage Particles L. Saleh, K.A. Noren, C.J. Noren, New England Biolabs, US | |
Tuesday May 5 | ||
| Back to Top | ||
| 8:00 | Keynotes: Nanotech & Cleantech & TechConnect | Theater AB |
| Session chair: Jeff Moseley, Greater Houston Partnership, Shushana Castle, Clinton Global Initiative Member/Millennium Water Alliance, US | ||
| 8:00 | Welcome TechConnect World to Houston J. Moseley, Greater Houston Partnership, US | |
| 8:15 | Can Uncle Sam Cure What Ails Clean Tech? P. Dickerson, HaynesBoone, former COO Office of Energy Efficiency & Renewable Energy, DOE, US (bio) | |
| 8:45 | Welcome to Houston B. White, City of Houston, Mayor, US | |
| 9:00 | Flying into the Future: Continental’s Commitment to the Environment L. Kellner, Continental Airlines, CEO, US (bio) | |
| 9:30 | RUSNANO: Driving the Nanotech Industry Growth A. Chubais, RUSNANO, CEO, RU | |
| Back to Top | ||
| 4:00 | POSTERS | Expo Hall |
| Back to Top | ||
| Phage Nanotechnology | Expo Hall | |
| - | Development of Novel Landscape Phage Libraries and Their Use for Selection of Phage Probes for Staphylococcus aureus C. Xu, S.B. Price, S. Kitchens, V.A. Petrenko, Auburn University, US | |
| - | Selection of SKBR-3 breast cancer cell-binding and internalizing peptides by landscape phage display G. Abbineni, S. Modali, B. Mroczka, V.A. Petrenko, C. Mao, University of Oklahoma, US | |
| - | Sensing humidity using phage-nanoparticle assembly C. Mao, A. Liu, G. Abbineni, University of Oklahoma, US | |
| - | Pharmaceutical Liposomes Targeted to PC3 Prostate Carcinoma Cells by Fusion Phage Proteins P.K. Jayanna, T. Wang, D. Bedi, P. Deinnocentes, R.C. Bird, V.P. Torchilin, V.A. Petrenko, Auburn University, US | |
| - | Landscape Phage Probes for Breast Cancer Cell Receptors O.A. Fagbohun, D. Bedi, P.K. Jayanna, P.A. Deinnocentes, R.C. Bird, V.A. Petrenko, Auburn University, US | |
| - | Viral Gene Therapy for Expression of Transporter Gene in Pancreatic Tumor Cells: A Novel Approach A. Paul, A. Kulamarva, M. Malhotra, S. Prakash, McGill University, CA | |
| - | Creation of a self-assembling molecular transistor scaffold S. White, P.G. Stockley, G. Davies, C. Wälti, Astbury Centre, University of Leeds, UK | |
| - | Chromato-panning: a chromatographic biopanning procedure for phage display libraries in supermacroporous cryogel W. Noppe, I. Yu Galaev, B. Mattiasson, H. Deckmyn, Katholieke Universiteit Leuven Campus Kortrijk, BE | |
Wednesday May 6 | ||
| Back to Top | ||
| 1:30 | POSTERS | Expo Hall |
Topics & Application Areas
Online abstract submissions are now being accepted. Proposed topics include, but are not be limited to:
- Amplification & Self Assemblage of Phage Particles
- Engineering of phage shape & function
- Imaging Phage Probes
- Phage-Based Biorecognition Interfaces in Biosensors
- Phage-Based Patient-Specific Navigation Systems
- Phage-Derived Interfaces between Organic & Inorganic Materials
- Phage-derived Vehicles for Gene & Drug Delivery
- Phage-Driven Synthesis of Inorganic Nanomaterials
- Site-Directed Chemical Modification of Phage Particles
- Structure of Filamentous Phage Particles & Their Components
- Distinct Viral Nanomaterials
- Other
Journal Submissions
Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)
Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine) is a newly established, international, peer-reviewed journal published quarterly. Nanomedicine publishes basic, clinical, and engineering research in the innovative field of nanomedicine. Article categories include basic nanomedicine, diagnostic nanomedicine, experimental nanomedicine, clinical nanomedicine, and engineering nanomedicine, pharmacological nanomedicine.
For consideration into the Nanomedicine: Nanotechnology, Biology and Medicine journal please select the “Submit to Nanomedicine: Nanotechnology, Biology and Medicine” button during the on-line submission procedure. You may only select a single journal during the submission process.